Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with LABT: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
LABT
Lakewood-Amedex Biotherapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
LABT, dashed
LLY
ELI Lilly & Co
Change
1,379.51
▼
−2.71%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
0.60
▲
+216.04%
Regular session
Nov 5 '26
Mkt cap
$271,743
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
LABT
Lakewood-Amedex Biotherapeutics Inc.
1,379.51
▼
−2.71%
Price
0.60
▲
+216.04%
$1.3T
Mkt cap
$271,743
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,379.51
▼
−2.71%
vs
LABT
0.60
▲
+216.04%
Regular session
Nov 5 '26